Gene | Genotype | Lung cancer patients (GPx levels) | p value | Controls (GPx levels) | p value | Total p value | ||
---|---|---|---|---|---|---|---|---|
n | Mean ± SE | n | Mean ± SE | |||||
CYP1A1 m1 | T/T | 121 | 47.51 ± 4.52 |  | 138 | 55.44 ± 0.60 |  | <0.01* |
 | T/C | 89 | 45.77 ± 2.45 | 0.01* | 98 | 55.15 ± 0.69 | 0.74 | <0.01* |
 | C/C | 28 | 43.42 ± 2.02 | <0.01* | 14 | 51.42 ± 1.74 | 0.79 | 0.06 |
CYP1A1 m2 | A/A | 71 | 48.18 ± 6.45 |  | 196 | 59.35 ± 0.33 |  | <0.01* |
 | A/G | 156 | 44.02 ± 1.75 | <0.01* | 34 | 55.26 ± 0.65 | 0.17 | <0.02* |
 | G/G | 11 | 45.94 ± 2.93 | 0.01* | 20 | 54.67 ± 0.91 | 0.53 | <0.01* |
GSTM1 | +/+ | 174 | 46.22 ± 1.74 |  | 187 | 57.69 ± 0.36 |  | <0.01* |
 | –/– | 64 | 40.87 ± 2.69 | 0.33 | 63 | 54.41 ± 0.84 | 0.21 | <0.01* |
GSTT1 | +/+ | 192 | 46.66 ± 1.53 |  | 224 | 55.50 ± 0.47 |  | <0.001* |
 | –/– | 46 | 36.95 ± 3.95 | 0.05* | 26 | 51.69 ± 1.12 | 0.07 | <0.001* |